Asha Therapeutics presents at 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

Updated: Jul 16, 2022

Sam Shrivastava (Asha CEO) and Dr. Bradlee Heckmann (Asha CSO) present updates on neuro-oncology assets and ASHA-044

Recent Posts

November 13, 2024 09:30 AM Eastern Standard Time CINCINNATI--( BUSINESS WIRE )-- Asha Therapeutics (Asha), a life sciences company...

CINCINNATI--(BUSINESS WIRE)--Asha Therapeutics (Asha) (www.ashatherapeutics.com), a life sciences company designing de novo disease...

CINCINNATI--(BUSINESS WIRE)--Asha Therapeutics (Asha), (www.ashatherapeutics.com), a life sciences company, is leveraging its...